IDH.L Regulatory News (IDH)

4 Jan 2010 07:00



Immunodiagnostic Systems Holdings plc

Five year distribution agreement

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of diagnostic testing kits for the clinical and research markets, announces that Technogenetics s.r.l. ("Technogenetics") of Milan, Italy has signed a five year distribution agreement with A. Menarini Diagnostics ("Menarini") covering Europe for an automated test system, the Zenit RA, together with a panel of 21 tests for the diagnosis of autoimmune diseases. The Zenit RA is an OEM version of the IDS-iSYS system.

On 5 October 2009 IDS announced that it had signed an OEM manufacturing and supply agreement with Technogenetics, a subsidiary of Bouty S.p.A, the clinical diagnostics company (see RNS Reach number 1950A). As part of this agreement IDS will supply IDS-iSYS systems and consumables to Technogenetics on an OEM basis. These systems, branded as the Zenit RA, and consumables will be sold by Menarini as 'closed system' instruments throughout the whole of Europe and countries of the former Soviet Union such as Russia and Ukraine. Menarini is a leading company in the diagnostic field, with 14 direct subsidiaries, 1,000 employees and a consolidated turnover of 320 million Euros.

Commenting on the distribution agreement, Lorenzo Castellini, President of the Bouty Group, said: "We expect that over the five years the distribution agreement with A. Menarini Diagnostics will generate approximately €12 million in revenues from sales of diagnostic kits manufactured by Technogenetics with additional income from sales of instruments and ancillary reagents supplied by IDS."

Enquiries: